{"id":597,"date":"2025-10-27T09:07:57","date_gmt":"2025-10-27T16:07:57","guid":{"rendered":"https:\/\/getasecondopinion.ai\/blog\/?p=597"},"modified":"2025-10-28T06:22:44","modified_gmt":"2025-10-28T13:22:44","slug":"understanding-the-shift-hormonal-imbalance-high-cortisol-perimenopause-menopause-for-women","status":"publish","type":"post","link":"https:\/\/www.getasecondopinion.ai\/blog\/health-info\/conditions\/understanding-the-shift-hormonal-imbalance-high-cortisol-perimenopause-menopause-for-women\/","title":{"rendered":"Understanding the Shift: Hormonal Imbalance, High Cortisol, Perimenopause &#038; Menopause for Women"},"content":{"rendered":"\n<p>Women&#8217;s Hormonal Health &#8211; Effects of Cortisol, Menopause, Perimenopause &amp; New Treatments for 2026<\/p>\n\n\n\n<p>The intricate interplay of hormones shapes women\u2019s health across their lifespan, influencing physical, emotional, metabolic, and reproductive wellbeing. Among the most consequential hormonal axes are cortisol regulation, the menopause transition (encompassing perimenopause and postmenopausal states), and broader disorders of hormonal imbalance. The convergence of these phenomena, often during critical midlife decades, poses significant clinical, personal, and societal challenges. Recent research has shed new light on the prevalence, seriousness, and far-reaching impacts of each of these conditions. Moreover, an explosion of innovation &#8211; including clinical trials for novel therapies, heralds a new chapter in symptom management and disease prevention. This article offers a comprehensive synthesis of data-rich insights into these domains, including prevalence and age-of-onset data, symptom severity, diagnostic innovations, and both established and experimental treatments relevant to 2026.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Overview of Female Hormonal Conditions<\/strong><\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Condition<\/strong><\/td><td><strong>Prevalence among adult women (%)<\/strong><\/td><td><strong>Typical Age of Onset<\/strong><\/td><td><strong>% with Moderate or Worse Symptoms<\/strong><\/td><td><strong>Notes on Severity\/Impact<\/strong><\/td><\/tr><tr><td>High Cortisol\/Hypercorisolism<\/td><td>~2-5% (at risk pops.)<\/td><td>Any, peak 20-50<\/td><td>70% (in Cushing\u2019s, moderate-severe)<\/td><td>Rare overall; higher in comorbid conditions; risk \u2191 with age<\/td><\/tr><tr><td>Perimenopause<\/td><td>100% (universal by ~55)<\/td><td>40-50<\/td><td>~75% (VMS symptoms); 10-15% severe<\/td><td>Symptoms may persist up to 10+ years<\/td><\/tr><tr><td>Menopause<\/td><td>100% (universal by ~55)<\/td><td>45-55 (avg. 51 US)<\/td><td>~75-80% VMS; 20-30% severe<\/td><td>Postmenopause: GSM ~50-80%; joint pain 50-60%<\/td><\/tr><tr><td>General Hormonal Imbalance<\/td><td>~40-60%*<\/td><td>Varies: teens-postmeno<\/td><td>20-40% moderate-severe<\/td><td>Estimates include PCOS, hypothyroid, low progesterone, etc.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p>*Derived from menstrual tracking and survey data; ~47% of cycles lack ovulation, 22% low progesterone.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Experimental Treatments for Key Female Hormonal Conditions (2025-2026)<\/strong><\/h3>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Drug \/ Therapy<\/strong><\/td><td><strong>Condition<\/strong><\/td><td><strong>Mechanism<\/strong><\/td><td><strong>Phase (2025-26)<\/strong><\/td><td><strong>Key Details\/Trial Outcomes<\/strong><\/td><\/tr><tr><td>Elinzanetant (Lynkuet)<\/td><td>Menopause (VMS)<\/td><td>NK1\/NK3 receptor antagonist, non-hormone<\/td><td>Approved 2025 (US\/EU)<\/td><td>73% reduction in VMS by week 12; improved sleep\/QoL<\/td><\/tr><tr><td>Fezolinetant<\/td><td>Menopause (VMS)<\/td><td>NK3 receptor antagonist, non-hormone<\/td><td>Approved\/Phase 3<\/td><td>Rapid, significant symptom relief; alternative to HT<\/td><\/tr><tr><td>Crinecerfont (Crenessity)<\/td><td>Classic CAH (high andrgens\/cortisol)<\/td><td>CRH receptor antagonist<\/td><td>Phase 3 (FDA approved)<\/td><td>Glucocorticoid-sparing effect, reduced androgen levels<\/td><\/tr><tr><td>Semaglutide<\/td><td>PCOS, metabolic syndrome<\/td><td>GLP-1 receptor agonist (weight loss, metabolic)<\/td><td>Phase 2\/3<\/td><td>Reduces hepatic fat, improves insulin sensitivity<\/td><\/tr><tr><td>Inositol\/Berberine<\/td><td>PCOS\/hormonal imbalance<\/td><td>Nutraceutical, insulin sensitizer<\/td><td>Observational\/Phase 2<\/td><td>Reduces androgens, improves ovulation<\/td><\/tr><tr><td>Wearable\/At-Home Hormone Tech<\/td><td>Hormonal imbalance\/menopause<\/td><td>Real-time hormone tracking<\/td><td>Commercial\/validation<\/td><td>Enables personalized management, early diagnosis<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<div class=\"wp-block-group unauthenticated invisible has-global-padding is-layout-constrained wp-container-core-group-is-layout-675f737c wp-block-group-is-layout-constrained\" style=\"padding-right:var(--wp--preset--spacing--30);padding-left:var(--wp--preset--spacing--30)\">\n<div class=\"wp-block-group cta-background has-background has-global-padding is-content-justification-left is-layout-constrained wp-container-core-group-is-layout-64f51f8a wp-block-group-is-layout-constrained\" style=\"border-style:none;border-width:0px;border-radius:30px;background-color:#f6fffc;padding-top:var(--wp--preset--spacing--30);padding-right:var(--wp--preset--spacing--30);padding-bottom:var(--wp--preset--spacing--30);padding-left:var(--wp--preset--spacing--30);box-shadow:var(--wp--preset--shadow--natural);background-image:url(&apos;https:\/\/getasecondopinion.ai\/blog\/wp-content\/uploads\/2025\/10\/cta-background-03b.webp&apos;);background-position:100% 100%;background-repeat:no-repeat;background-size:contain;background-attachment:scroll;\">\n<div class=\"wp-block-group has-global-padding is-layout-constrained wp-container-core-group-is-layout-153751c2 wp-block-group-is-layout-constrained\" style=\"padding-bottom:10px\">\n<h3 class=\"wp-block-heading has-text-align-center has-accent-1-color has-text-color has-link-color has-large-font-size wp-elements-9363713a6feba58457096f3ce3e67f32\">Stop Overpaying for Meds.<\/h3>\n\n\n\n<p>Coupons aren\u2019t your only option &#8211; see if safer, more effective, and lower-cost alternatives are available. It\u2019s fast, personalized, and 100% free. <strong><a href=\"https:\/\/getasecondopinion.ai\/intro-summary\" target=\"_blank\" rel=\"noreferrer noopener\">Learn More \u2192<\/a><\/strong><\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>High Cortisol in Women<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Epidemiology and Life Stage Variation<\/strong><\/h3>\n\n\n\n<p>High cortisol, known also as hypercortisolism, is most famously linked to Cushing\u2019s syndrome but can appear sub-clinically in women exposed to chronic stress or with related metabolic disorders. True Cushing\u2019s syndrome is extremely rare, affecting roughly 1-3 per million annually; however, mild excess cortisol (detected in up to 5% of women with resistant hypertension or poorly controlled diabetes) is much more common, with an estimated prevalence rate in at-risk populations of 2-5%, and significantly more prevalent among women than men (by a 3:1 ratio).<\/p>\n\n\n\n<p>Epidemiological data shows that cortisol secretion is dynamic: in childhood and adolescence, levels fluctuate with growth and puberty, with girls reaching mean cortisol levels of ~11 mcg\/dL at age 13, rising to 15.9 mcg\/dL by 16. Adult women typically display cortisol variations influenced by menstrual cycles, pregnancy (where levels may rise 2-4X), and life stresses. With aging, baseline cortisol not only rises but also becomes more erratic, with the elderly exhibiting higher and more dysregulated diurnal patterns &#8211; an effect more pronounced in postmenopausal women.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Health Outcomes and Consequences<\/strong><\/h3>\n\n\n\n<p>Chronic high cortisol burdens nearly every organ system. Consequences include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Metabolic:<\/strong> Central obesity, hypertension, hyperglycemia, dyslipidemia, insulin resistance, increased risk of type 2 diabetes.<\/li>\n\n\n\n<li><strong>Cardiovascular:<\/strong> Hypertension, heart failure (~6X risk), myocardial infarction (~2X risk), stroke (~4.5X risk).<\/li>\n\n\n\n<li><strong>Musculoskeletal:<\/strong> Muscle atrophy, osteoporosis (in up to 30% of cases).<\/li>\n\n\n\n<li><strong>Neuropsychiatric:<\/strong> Depression, anxiety, cognitive deficits, memory loss.<\/li>\n\n\n\n<li><strong>Immune Dysfunction:<\/strong> Increased infections, delayed wound healing.<\/li>\n\n\n\n<li><strong>Reproductive and Skin:<\/strong> Irregular menses or amenorrhea, fertility impairment, acne, hirsutism, thin\/bruisable skin, purple striae.<\/li>\n\n\n\n<li><strong>Long-Term Mortality:<\/strong> Women with chronic hypercortisolism face 3.5-5 times higher mortality risk.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Diagnosis and Measurement<\/strong><\/h3>\n\n\n\n<p>Diagnosis of cortisol excess has improved, with multi-modal lab and imaging approaches:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Initial Screening:<\/strong>\n<ul class=\"wp-block-list\">\n<li>Late-night salivary cortisol (\u22652 ng\/ml highly sensitive)<\/li>\n\n\n\n<li>24-hr urinary free cortisol (UFC): >220-330 nmol\/24h diagnostic<\/li>\n\n\n\n<li>Low\/high dose dexamethasone suppression test (DST)<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Confirmatory Tests:<\/strong>\n<ul class=\"wp-block-list\">\n<li>ACTH levels (distinguish pituitary vs. adrenal vs. iatrogenic origin)<\/li>\n\n\n\n<li>Imaging: MRI\/CT for suspected tumors<\/li>\n\n\n\n<li>Hair cortisol for long-term stress measurement and risk assessment<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p>Notably, DST-based population studies (e.g., MOMENTUM trial) offer real-world prevalence estimates for subclinical hypercortisolism within resistant hypertension populations.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Treatment Options and New Experimental Therapies<\/strong><\/h3>\n\n\n\n<p><strong>Established therapies<\/strong> include normalization of lifestyle (stress management, sleep, diet), treating underlying causes (e.g., tumor excision, withdrawal of exogenous steroids), and pharmacological suppression of adrenal steroidogenesis (ketoconazole, metyrapone, mitotane, mifepristone, osilodrostat). Surgical intervention (e.g., minimally invasive adrenalectomy) is often curative in Cushing\u2019s due to adrenal adenoma.<\/p>\n\n\n\n<p><strong>Emerging\/Experimental:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>CRH receptor antagonists (crinecerfont, tildacerfont):<\/strong> Recently FDA approved for congenital adrenal hyperplasia, these agents can lower necessary steroid doses, thereby reducing iatrogenic complications (e.g., osteoporosis, metabolic syndrome), with pediatric and adult Phase 3 trial data showing reductions in glucocorticoid dose (18-27%) and androgen levels, while maintaining disease control.<\/li>\n\n\n\n<li><strong>Cabergoline and pasireotide:<\/strong> Although primarily for pituitary-driven Cushing\u2019s, may help suppress cortisol (pasireotide Phase II; cabergoline observational).<\/li>\n\n\n\n<li><strong>Hair cortisol monitoring:<\/strong> Research supports using HCC for tracking treatment response and risk profiling in high-stress\/at-risk populations.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Prevalence and Severity Insights<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Cushing\u2019s syndrome:<\/strong> Prevalence ~40\/million females; age of onset 20-50, peaking in the 3rd-4th decade.<\/li>\n\n\n\n<li><strong>Subclinical\/functional hypercortisolism:<\/strong> May reach 2-5% among women with metabolic syndrome, rising with age and comorbidities.<\/li>\n\n\n\n<li><strong>Severity:<\/strong> 70-80% with overt hypercortisolism report moderate to severe symptoms, though true Cushing\u2019s remains rare. Subclinical forms may still confer up to 2-5X increased mortality risk.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Key Management Advice for 2026<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Screen high-risk populations (resistant hypertension, uncontrolled diabetes, persistent obesity) routinely for cortisol abnormalities.<\/strong><\/li>\n\n\n\n<li><strong>Adopt precision medicine:<\/strong> Genetic, lifestyle, sleep, and stress factors must guide care plans.<\/li>\n\n\n\n<li><strong>Monitor for comorbidities<\/strong> (CVD, osteoporosis, depression) even after biochemical remission.<\/li>\n\n\n\n<li><strong>Stay abreast of CRH antagonist indications:<\/strong> These drugs may soon expand into treatment of other hypercortisolism-driven conditions.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Perimenopause<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Epidemiology and Life Course Variability<\/strong><\/h3>\n\n\n\n<p>Perimenopause is the often-turbulent transition leading up to menopause, marked by erratic ovarian hormone fluctuations, beginning in the early-to-mid 40s and lasting an average of 4-7 years (range 2-10), with symptom onset occasionally in the late 30s. Every woman who lives through her 50s will experience perimenopause, but the timing, symptom profile, and severity are highly individual.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Onset:<\/strong> Median age of perimenopause is 47; symptoms escalate as menopause nears &#8211; median age 51 (U.S.).<\/li>\n\n\n\n<li><strong>Symptom Prevalence:<\/strong> Up to 75-80% experience vasomotor symptoms (VMS; hot flashes, night sweats), but only 10-15% experience severe symptoms needing treatment.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Major Perimenopausal Symptoms and Their Prevalence<\/strong><\/h3>\n\n\n\n<p><strong>Vasomotor Symptoms (VMS)<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Hot flashes and night sweats affect ~75-80% of perimenopausal women.<\/li>\n\n\n\n<li>Severity: 10-15% report disabling VMS; mean duration is 7-10 years, with persistence into postmenopause for some.<\/li>\n<\/ul>\n\n\n\n<p><strong>Sleep Disturbances<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>40-60% report insomnia, often secondary to night sweats.<\/li>\n\n\n\n<li>Sleep disruption increases daytime fatigue, mood swings, and cognitive impairment.<\/li>\n<\/ul>\n\n\n\n<p><strong>Mood Changes and Brain Fog<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Anxiety and depression rise in ~25% of perimenopausal women; new or worsening episodes.<\/li>\n\n\n\n<li>Brain fog (memory\/concentration deficits) is noted by 60-70%.<\/li>\n<\/ul>\n\n\n\n<p><strong>Genitourinary Syndrome (Vaginal dryness, urinary symptoms)<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>30-50% in perimenopause (rising sharply in postmenopause).<\/li>\n<\/ul>\n\n\n\n<p><strong>Joint Pain, Headaches, Skin Changes<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>40-60% report musculoskeletal discomfort; headaches, and dry skin are also more common.<\/li>\n<\/ul>\n\n\n\n<div class=\"wp-block-group unauthenticated invisible has-global-padding is-layout-constrained wp-container-core-group-is-layout-675f737c wp-block-group-is-layout-constrained\" style=\"padding-right:var(--wp--preset--spacing--30);padding-left:var(--wp--preset--spacing--30)\">\n<div class=\"wp-block-group cta-background has-background has-global-padding is-content-justification-left is-layout-constrained wp-container-core-group-is-layout-64f51f8a wp-block-group-is-layout-constrained\" style=\"border-style:none;border-width:0px;border-radius:30px;background-color:#fff6eb;padding-top:var(--wp--preset--spacing--30);padding-right:var(--wp--preset--spacing--30);padding-bottom:var(--wp--preset--spacing--30);padding-left:var(--wp--preset--spacing--30);box-shadow:var(--wp--preset--shadow--natural);background-image:url(&apos;https:\/\/getasecondopinion.ai\/blog\/wp-content\/uploads\/2025\/10\/cta-background-02.webp&apos;);background-position:100% 100%;background-repeat:no-repeat;background-size:contain;background-attachment:scroll;\">\n<div class=\"wp-block-group has-global-padding is-layout-constrained wp-container-core-group-is-layout-9d2deb30 wp-block-group-is-layout-constrained\" style=\"padding-top:0px;padding-right:0px;padding-bottom:10px\">\n<h3 class=\"wp-block-heading has-text-align-center has-accent-1-color has-text-color has-link-color has-large-font-size wp-elements-e1a2b4d20c009cbe1ac01729b645a8a1\">Experiencing Side Effects? <br>Let\u2019s Rethink Your Meds.<\/h3>\n\n\n\n<p>Explore treatment options that may work better for your body &#8211; with fewer side effects and lower costs. It\u2019s fast, free, and tailored to you. <strong><a href=\"https:\/\/getasecondopinion.ai\/intro-summary\" target=\"_blank\" rel=\"noreferrer noopener\">Learn More \u2192<\/a><\/strong><\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Risk Factors and Variation<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Higher BMI, smoking, low physical activity, and stress exacerbate symptoms.<\/li>\n\n\n\n<li>Race\/ethnic variations: African-American women often have earlier and more severe hot flashes than White\/Asian peers.<\/li>\n\n\n\n<li>Genetic predispositions shape both onset and intensity.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Impact on Daily Functioning<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Work:<\/strong> Up to 20% reduce hours or consider job changes &#8211; a significant economic burden (U.S. losses at $1.8 billion\/year).<\/li>\n\n\n\n<li><strong>Home\/Social:<\/strong> Symptoms disrupt relationships, sex life, and daily enjoyment. Stigma and lack of awareness\/education exacerbate suffering.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Emerging Treatments and Innovations<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Non-hormonal neurokinin antagonists:<\/strong> Elinzanetant and fezolinetant target VMS via hypothalamic pathways and are newly FDA-approved\/late-phase. These offer relief for women contraindicated for estrogen (e.g., cancer risk).<\/li>\n\n\n\n<li><strong>Personalized HRT:<\/strong> Lower-dose, transdermal, and bioidentical options, customized by genetics and symptom profile.<\/li>\n\n\n\n<li><strong>Wearable and at-home hormone diagnostics:<\/strong> Enable detection of steep hormone fluctuations for real-time, individualized management.<\/li>\n\n\n\n<li><strong>Digital health:<\/strong> Telehealth, apps for tracking, and AI-powered symptom support normalized as first-line care.<\/li>\n\n\n\n<li><strong>Supplements:<\/strong> Inositol, phytoestrogens, and adaptogenic blends show early promise for select symptoms.<\/li>\n\n\n\n<li><strong>Lifestyle focus:<\/strong> CBT, mindfulness, exercise, and dietary approaches remain foundational, with mounting evidence of efficacy.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Best Practice Management in 2026<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Individualize interventions:<\/strong> Leverage at-home diagnostics, symptom diaries, and digital health tools.<\/li>\n\n\n\n<li><strong>Prioritize evidence-based options:<\/strong> VMS &#8211; hormonal or neurokinin-based first-line; mood\/cognition &#8211; CBT and SSRIs\/SNRIs as appropriate.<\/li>\n\n\n\n<li><strong>Early intervention:<\/strong> Address perimenopausal symptoms before full loss of menstruation to prevent rapid quality-of-life decline.<\/li>\n\n\n\n<li><strong>Educate and destigmatize:<\/strong> Bridge awareness gaps via employer, clinical, and public health campaigns.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Menopause<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Demographics and Epidemiology<\/strong><\/h3>\n\n\n\n<p>Menopause is defined as 12 consecutive months without menstruation due to ovarian follicular exhaustion, typically between ages 45-55, with a median age of 51 (U.S.). Globally, over 1 billion women are postmenopausal as of 2025, and this demographic will exceed 1.2 billion by 2030.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Symptom Burden and Persistence<\/strong><\/h3>\n\n\n\n<p>As with perimenopause, menopause features:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Vasomotor Symptoms:<\/strong> 75-80%, persistence averages 7-10 years, with ~20-30% experiencing severe, life-disrupting symptoms.<\/li>\n\n\n\n<li><strong>Sleep Disruption:<\/strong> 40-60% (insomnia, resulting in fatigue and mood disturbance).<\/li>\n\n\n\n<li><strong>Genitourinary and Sexual Dysfunction:<\/strong> 50-80% (vaginal dryness, dyspareunia, recurrent UTIs).<\/li>\n\n\n\n<li><strong>Joint and Muscular Pain:<\/strong> 50-60%.<\/li>\n\n\n\n<li><strong>Cognitive Changes:<\/strong> \u201cBrain fog\u201d in 60-70%, sometimes persisting for years.<\/li>\n\n\n\n<li><strong>Mood Disorders:<\/strong> ~25% develop or worsen depression\/anxiety.<\/li>\n<\/ul>\n\n\n\n<p><strong>Health risks rise:<\/strong> The decline in estrogen increases osteoporosis risk (osteoporosis occurs in up to 20% of women over 60; osteopenia in 50%) and cardiovascular disease risk (heart disease becomes #1 killer post-menopause).<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Societal Impact<\/strong><\/h3>\n\n\n\n<p>Menopausal symptoms are underdiagnosed and undertreated; up to 75% of women leave clinical encounters without targeted intervention for underlying hormonal change. Severe symptoms are linked to job loss, economic decline, and strained relationships. Social taboos and lack of provider training compound the problem.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Clinical Trends and Emerging Experimental Therapies<\/strong><\/h3>\n\n\n\n<p><strong>Hormone therapy (HT\/MHT):<\/strong> Remains the gold standard for VMS and GSM, yet only 10-15% of eligible U.S. women receive it, often due to concerns from earlier studies about cancer and vascular risk. Research since 2024 clarifies that early initiation (within 10 years of menopause or before age 60), lower doses, and transdermal application dramatically reduce risk and preserve benefit for bone, cardiovascular, cognitive, and urogenital health.<\/p>\n\n\n\n<p><strong>Non-hormonal therapies:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Neurokinin antagonists: Elinzanetant and fezolinetant now FDA-approved; clinical trials show &gt;70% reduction in moderate-severe hot flash frequency and significant sleep\/quality-of-life improvements, with rapid effect and excellent safety profile (most common side effects: mild headache, fatigue). These drugs fill a crucial gap for women who can\u2019t take estrogen, such as cancer survivors.<\/li>\n\n\n\n<li>SSRIs\/SNRIs, gabapentin, clonidine, and cognitive therapy: Useful for VMS, mood, and sleep.<\/li>\n\n\n\n<li>Personalized\/AI-driven care: Digital tools (telemedicine, apps, tracking devices) are mainstream in 2026, supporting adherence and personalization.<\/li>\n<\/ul>\n\n\n\n<p><strong>Post-2024 clinical guidance:<\/strong> Leading authorities (ESE, ACOG, The Menopause Society) advocate early, individualized treatment; ongoing provider education; careful evaluation of contraindications; shared decision making; and integration of holistic\/lifestyle approaches.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Quality of Life and Productivity<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Up to 1 in 5 women reduce working hours or leave jobs due to unmanaged menopausal symptoms.<\/li>\n\n\n\n<li>Cognitive and mood issues, musculoskeletal pain, and sexual dysfunction persist into the late 60s for many, with marked healthcare utilization and economic costs.<\/li>\n\n\n\n<li>Pressure from advocacy and health tech is increasing awareness, resulting in policy changes and improved healthcare infrastructure in 2026.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Hormonal Imbalance Beyond Menopause<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Epidemiology and Scope<\/strong><\/h3>\n\n\n\n<p>Hormonal imbalance is a collective term encompassing disorders like PCOS, thyroid dysfunction, hypothalamic amenorrhea, low progesterone, and estrogen\/testosterone\/DHEA dysregulation.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>As many as 40-60% of women experience hormonally mediated symptoms over a lifespan, with survey data showing 47% of cycles are anovulatory (lack ovulation), 22% low progesterone, and 13% elevated LH (all markers of potential PCOS or other imbalance).<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Seriousness, Diagnosis, and Gaps<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Prevalence:<\/strong> PCOS affects 6-13% of reproductive-aged women; up to 70% are undiagnosed worldwide. Hypothyroidism and low progesterone are common and often missed.<\/li>\n\n\n\n<li><strong>Delay in Diagnosis:<\/strong> &gt;50% of women wait &gt;6 months, and 1 in 3 over a year, for hormonal diagnoses, leading to missed opportunities for early intervention.<\/li>\n\n\n\n<li><strong>Dismissal and Access:<\/strong> 21% feel dismissed by providers; 32% cite financial barriers; 37% face geographic\/transport obstacles.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Health Outcomes and Risks<\/strong><\/h3>\n\n\n\n<p>Hormonal imbalances are implicated in mood disorders (depression, anxiety rise during both hormonal fluctuations and deficiencies), cycle disorders, infertility, metabolic syndrome, type 2 diabetes (PCOS: &gt;50% risk by age 40), obesity, cardiovascular disease, cognitive decline, osteoporosis, and more. These disruptions also reduce work productivity and diminish quality of life.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Clinical Innovations and Experimental Treatments (2025-2026)<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Metformin, Semaglutide (GLP-1 agonists):<\/strong> Expanding beyond diabetes\/weight loss, now tested in PCOS, where trials show improvements in ovulation, metabolic health, and hepatic steatosis.<\/li>\n\n\n\n<li><strong>Inositol, berberine, myo-inositol:<\/strong> Early data (Phase 2) support improvements in ovulation, androgen excess, and insulin sensitivity.<\/li>\n\n\n\n<li><strong>Personalized Supplements &amp; AI-driven care:<\/strong> Brands and clinicians are leveraging digital tracking, home hormone tests, and genetics to craft supplements and protocols for cycle- and life-stage-specific needs.<\/li>\n\n\n\n<li><strong>Wearable hormone diagnostics<\/strong> and <strong>cycle tracking apps:<\/strong> Help identify subtle patterns and tailor interventions in real time.<\/li>\n\n\n\n<li><strong>Experimental fertility protocols:<\/strong> Trials of rapid clomiphene protocols and personalized ovulation induction are ongoing.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Best Practice Recommendations for 2026<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Universal screening:<\/strong> Broader use of home-based and wearable hormone trackers to enable early detection.<\/li>\n\n\n\n<li><strong>Shared decision making:<\/strong> Address stigma, cost, and access barriers proactively.<\/li>\n\n\n\n<li><strong>Integrative approach:<\/strong> Combine pharmacology, dietary\/lifestyle, and psychological support for lasting benefit.<\/li>\n\n\n\n<li><strong>Policy and support:<\/strong> Governments and employers are now recognizing the economic and social impact, prompting the rollout of supportive policies and insurance reforms.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Treatment Guidelines and Advice for 2026<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Overarching Principles<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Personalized interventions:<\/strong> Leverage home diagnostics, wearable monitoring, and genetics for tailored plans.<\/li>\n\n\n\n<li><strong>Early intervention:<\/strong> Focus on prevention and early symptom management to forestall chronic disease progression.<\/li>\n\n\n\n<li><strong>Integrative care:<\/strong> Combine medical, psychological, and lifestyle support.<\/li>\n\n\n\n<li><strong>Destigmatization and education:<\/strong> Increase public understanding; equip clinicians and employers to recognize, diagnose, and support women in all hormonal life stages.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Evidence-Based Recommendations<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>For High Cortisol and Hypercortisolism:<\/strong>\n<ul class=\"wp-block-list\">\n<li>Screen at-risk groups, use combined lab\/imaging modalities.<\/li>\n\n\n\n<li>Treat underlying cause; CRH antagonists are now emerging as adjuncts to reduce steroid requirements.<\/li>\n\n\n\n<li>Long-term follow-up for cardiovascular\/metabolic complications is mandatory.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>For Perimenopause and Menopause:<\/strong>\n<ul class=\"wp-block-list\">\n<li>For severe VMS: Offer HT if within 10 years of onset\/under age 60 and no contraindications; otherwise, NK1\/NK3 antagonists are first-line nonhormonal alternatives.<\/li>\n\n\n\n<li>Address GSM with topical estrogens\/DHEA or SERM as appropriate.<\/li>\n\n\n\n<li>Lifestyle interventions (CBT, mindful stress reduction, regular exercise, dietary management) are essential adjuncts.<\/li>\n\n\n\n<li>Regularly reassess needs and tolerance of therapies.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>For Hormonal Imbalance:<\/strong>\n<ul class=\"wp-block-list\">\n<li>Diagnose using salivary, blood, and home test platforms.<\/li>\n\n\n\n<li>PCOS: Begin with lifestyle, add metformin, GLP-1 agonists, inositol\/berberine trials as appropriate.<\/li>\n\n\n\n<li>Address fertility early; support mental health needs.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>New Frontiers and Innovations<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>At-home hormone tracking<\/strong>, AI-powered health management, and virtual therapy uptake accelerate, enabling proactive management and democratizing care.<\/li>\n\n\n\n<li><strong>Personalized nutraceuticals:<\/strong> Tailored supplementation for PMS, PCOS, perimenopause, often guided by home monitoring results.<\/li>\n\n\n\n<li><strong>Sleep tech<\/strong> and environmental adaptations for vasomotor and cognitive symptoms &#8211; e.g., cooling pads and smart mattresses are widely adopted.<\/li>\n<\/ul>\n\n\n\n<p>Women\u2019s hormonal health is at a crossroads in 2026, with robust new epidemiological data clarifying the massive burden of high cortisol, perimenopause, menopause, and general hormonal imbalance. These conditions impact a majority of women at some point in their lives, with severe symptoms in up to 1 in 4. The expansion of research, new FDA approvals (such as elinzanetant and crinecerfont), advances in at-home diagnostics, and the shift toward personalized, digital, and behavioral interventions marks a transformative new era.<\/p>\n\n\n\n<p>Crucially, closing gaps in awareness, diagnosis, and access &#8211; via public and employer education, destigmatization, telemedicine, and insurance reform &#8211; will be as important as clinical innovations. Health leaders, clinicians, and patients must work together to implement evidence-based, personalized care plans, blending new pharmacology with lifestyle and psychosocial support.&nbsp;<\/p>\n\n\n\n<p>Ultimately, by integrating the latest research, emerging treatments, and best practices for digital communication, we can improve outcomes and quality of life for women everywhere as they navigate the challenges of hormonal health across their lifespan.<\/p>\n\n\n\n<div class=\"wp-block-group unauthenticated invisible has-global-padding is-layout-constrained wp-container-core-group-is-layout-675f737c wp-block-group-is-layout-constrained\" style=\"padding-right:var(--wp--preset--spacing--30);padding-left:var(--wp--preset--spacing--30)\">\n<div class=\"wp-block-group cta-background has-custom-off-white-background-color has-background has-global-padding is-content-justification-left is-layout-constrained wp-container-core-group-is-layout-64f51f8a wp-block-group-is-layout-constrained\" style=\"border-style:none;border-width:0px;border-radius:30px;padding-top:var(--wp--preset--spacing--30);padding-right:var(--wp--preset--spacing--30);padding-bottom:var(--wp--preset--spacing--30);padding-left:var(--wp--preset--spacing--30);box-shadow:var(--wp--preset--shadow--natural);background-image:url(&apos;https:\/\/getasecondopinion.ai\/blog\/wp-content\/uploads\/2025\/09\/cta-background-01.webp&apos;);background-position:100% 100%;background-repeat:no-repeat;background-size:contain;background-attachment:scroll;\">\n<div class=\"wp-block-group has-global-padding is-layout-constrained wp-container-core-group-is-layout-153751c2 wp-block-group-is-layout-constrained\" style=\"padding-bottom:10px\">\n<h3 class=\"wp-block-heading has-text-align-center has-accent-1-color has-text-color has-link-color has-large-font-size wp-elements-b6fe6b9c1e90c3ca0e3d22a4a0e21d9e\">Better Treatment, Lower Cost &#8211; No Catch.<\/h3>\n\n\n\n<p>Find safer, more effective medications with fewer side effects &#8211; often for less money. It\u2019s fast, free, and personalized. <strong><a href=\"https:\/\/getasecondopinion.ai\/intro-summary\" target=\"_blank\" rel=\"noreferrer noopener\">Learn More \u2192<\/a><\/strong><\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>References (32)<\/strong><\/h2>\n\n\n\n<ol class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/menopause\/\">www.who.int<br><\/a>Menopause &#8211; World Health Organization (WHO)<\/li>\n\n\n\n<li><a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-treatment-congenital-adrenal-hyperplasia\">www.fda.gov<br><\/a>FDA Approves New Treatment for Congenital Adrenal Hyperplasia<\/li>\n\n\n\n<li><a href=\"https:\/\/mlrb.net\/average-age-of-natural-menopause\/\">mlrb.net<br><\/a>The Average Age of Natural Menopause: What to Expect and Why It Matters &#8230;<\/li>\n\n\n\n<li><a href=\"https:\/\/www.pharmexec.com\/view\/fda-bayer-lynkuet-menopausal-hot-flashes\">www.pharmexec.com<br><\/a>FDA Approves Bayer\u2019s Lynkuet as First Dual Neurokinin Antagonist for &#8230;<\/li>\n\n\n\n<li><a href=\"https:\/\/medicalxpress.com\/news\/2025-10-fda-nonhormonal-drug-ease-menopause.html\">medicalxpress.com<br><\/a>FDA approves nonhormonal drug to ease menopause hot flashes and night &#8230;<\/li>\n\n\n\n<li><a href=\"https:\/\/www.pharmacytimes.com\/view\/fda-approves-elinzanetant-as-first-nonhormonal-therapy-for-menopause-vasomotor-symptoms\">www.pharmacytimes.com<br><\/a>FDA Approves Elinzanetant as First Nonhormonal Therapy for Menopause \u2026<\/li>\n\n\n\n<li><a href=\"https:\/\/www.cdc.gov\/diabetes\/risk-factors\/pcos-polycystic-ovary-syndrome.html\">www.cdc.gov<br><\/a>Diabetes and Polycystic Ovary Syndrome (PCOS) | Diabetes | CDC<\/li>\n\n\n\n<li><a href=\"https:\/\/diabetesjournals.org\/clinical\/article\/21\/4\/154\/1589\/Polycystic-Ovary-Syndrome-and-the-Metabolic\">diabetesjournals.org<br><\/a>Polycystic Ovary Syndrome and the Metabolic Syndrome<\/li>\n\n\n\n<li><a href=\"https:\/\/www.mayo.edu\/research\/clinical-trials\/diseases-conditions\/polycystic-ovary-syndrome-%28pcos%29\">www.mayo.edu<br><\/a>Polycystic ovary syndrome (PCOS) &#8211; Mayo Clinic<\/li>\n\n\n\n<li><a href=\"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2024-0440\/html\">www.degruyterbrill.com<br><\/a>CRH receptor antagonist crinecerfont&nbsp; &#8211;&nbsp; a promising new treatment option &#8230;<\/li>\n\n\n\n<li><a href=\"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/1750-1172-7-41\">ojrd.biomedcentral.com<br><\/a>Cushing\u2019s disease &#8211; Orphanet Journal of Rare Diseases<\/li>\n\n\n\n<li><a href=\"https:\/\/isturisa.com\/hcp\/prevalence-impact\/\">isturisa.com<br><\/a>Understanding Cushing\u2019s Disease &#8211; Prevalence &amp; Impact<\/li>\n\n\n\n<li><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT06829537\">clinicaltrials.gov<br><\/a>Study Details | NCT06829537 | Study of the Prevalence of Endogenous &#8230;<\/li>\n\n\n\n<li><a href=\"https:\/\/www.after50health.com\/cortisol-levels-in-blood-test-results-normal-low-and-high-ranges-for-adult-men-and-women-explained.html\">www.after50health.com<br><\/a>Cortisol Levels in Blood Test Results: Normal, Low, and High Ranges for &#8230;<\/li>\n\n\n\n<li><a href=\"https:\/\/soula.care\/blog\/stress-and-anxiety\/normal-cortisol-levels-by-age\">soula.care<br><\/a>Normal Cortisol Level Chart by Age | Age Normal Cortisol Level Guide<\/li>\n\n\n\n<li><a href=\"https:\/\/www.adrenal.com\/blog\/the-dangers-of-excess-cortisol-understanding-hypercortisolism-and-its-complications\">www.adrenal.com<br><\/a>The Dangers of Excess Cortisol: Understanding Hypercortisolism and Its &#8230;<\/li>\n\n\n\n<li><a href=\"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-024-04221-2\">bmccardiovascdisord.biomedcentral.com<br><\/a>Higher hair cortisol levels associated with previous cardiovascular &#8230;<\/li>\n\n\n\n<li><a href=\"https:\/\/www.webmd.com\/a-to-z-guides\/cortisol-test\">www.webmd.com<br><\/a>Cortisol Test: Understanding High vs. Low Cortisol Levels &#8211; WebMD<\/li>\n\n\n\n<li><a href=\"https:\/\/www.rupahealth.com\/post\/saliva-testing-cortisol-and-hormone-test-result-interpretation-guide\">www.rupahealth.com<br><\/a>Saliva Testing: Cortisol and Hormone Test Result Interpretation Guide<\/li>\n\n\n\n<li><a href=\"https:\/\/academic.oup.com\/jcem\/article\/109\/4\/e1365\/7256799\">academic.oup.com<br><\/a>Crinecerfont in a First Clinical Application of a CRH Antagonist &#8230;<\/li>\n\n\n\n<li><a href=\"https:\/\/mlrb.net\/how-often-do-hot-flashes-happen-during-perimenopause\/\">mlrb.net<br><\/a>How Often Do Hot Flashes Happen During Perimenopause? A Comprehensive &#8230;<\/li>\n\n\n\n<li><a href=\"https:\/\/mlrb.net\/acog-releases-clinical-guidelines-on-management-of-menopausal-symptoms\/\">mlrb.net<br><\/a>ACOG Releases New Clinical Guidelines for Menopausal Symptom Management &#8230;<\/li>\n\n\n\n<li><a href=\"https:\/\/www.healthline.com\/health\/menopause\/how-common-are-hot-flashes-in-menopause\">www.healthline.com<br><\/a>How Common Are Hot Flashes in Menopause? &#8211; Healthline<\/li>\n\n\n\n<li><a href=\"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-024-19280-5\">bmcpublichealth.biomedcentral.com<br><\/a>Mapping global prevalence of menopausal symptoms among middle-aged &#8230;<\/li>\n\n\n\n<li><a href=\"https:\/\/www.joinmidi.com\/post\/menopause-statistics\">www.joinmidi.com<br><\/a>Menopause Statistics, Facts, &amp; Latest Research for 2024<\/li>\n\n\n\n<li><a href=\"https:\/\/www.healthspectra.com\/6-womens-health-trends-to-watch-in-2025-backed-by-data\/\">www.healthspectra.com<br><\/a>6 Women\u2019s Health Trends to Watch in 2025 (Backed by Data)<\/li>\n\n\n\n<li><a href=\"https:\/\/www.bayer.com\/en\/us\/news-stories\/elinzanetant-phase-3-study-for-vasomotor-symptoms\">www.bayer.com<br><\/a>Elinzanetant meets all primary and secondary endpoints in Phase III &#8230;<\/li>\n\n\n\n<li><a href=\"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2838538\">jamanetwork.com<br><\/a>Elinzanetant for the Treatment of Vasomotor Symptoms Associated With &#8230;<\/li>\n\n\n\n<li><a href=\"https:\/\/www.ese-hormones.org\/news\/press-release-ese-announces-new-clinical-practice-guideline-for-management-and-evaluation-of-menopause-and-the-perimenopause\/\">www.ese-hormones.org<br><\/a>Press release: ESE announces new Clinical Practice Guideline for &#8230;<\/li>\n\n\n\n<li><a href=\"https:\/\/www.contemporaryobgyn.net\/view\/fda-approves-elinzanetant-lynkuet-for-vasomotor-menopausal-symptoms\">www.contemporaryobgyn.net<br><\/a>FDA approves elinzanetant (Lynkuet) for vasomotor menopausal symptoms<\/li>\n\n\n\n<li><a href=\"https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/polycystic-ovary-syndrome\">www.who.int<br><\/a>Polycystic ovary syndrome<\/li>\n\n\n\n<li><a href=\"https:\/\/clinconnect.io\/blog\/future-breakthroughs-in-managing-pcos-fibroids-hormone-therapy-trials\">clinconnect.io<br><\/a>ClinConnect | Future Breakthroughs in Managing PCOS, Fibroids<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Women&#8217;s Hormonal Health &#8211; Effects of Cortisol, Menopause, Perimenopause &amp; New Treatments for 2026 The intricate interplay of hormones shapes women\u2019s health across their lifespan, influencing physical, emotional, metabolic, and reproductive wellbeing. Among the most consequential hormonal axes are cortisol regulation, the menopause transition (encompassing perimenopause and postmenopausal states), and broader disorders of hormonal imbalance. [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":599,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[37],"tags":[250,253,255,249,251,256,252,254,257],"class_list":["post-597","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-conditions","tag-cortisol-and-menopause","tag-emerging-menopause-treatments","tag-high-cortisol-in-women","tag-hormonal-imbalance-women","tag-menopause-treatment-2026","tag-perimenopause-hormone-therapy","tag-perimenopause-symptoms","tag-signs-of-hormonal-imbalance","tag-womens-hormonal-health"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Understanding the Shift: Hormonal Imbalance, High Cortisol, Perimenopause &amp; Menopause for Women - Get a Second Opinion<\/title>\n<meta name=\"description\" content=\"Comprehensive guide to women\u2019s hormonal health: signs, prevalence, and risks of high cortisol, perimenopause, menopause, and emerging 2026 treatments.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.getasecondopinion.ai\/blog\/health-info\/conditions\/understanding-the-shift-hormonal-imbalance-high-cortisol-perimenopause-menopause-for-women\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Understanding the Shift: Hormonal Imbalance, High Cortisol, Perimenopause &amp; Menopause for Women - Get a Second Opinion\" \/>\n<meta property=\"og:description\" content=\"Comprehensive guide to women\u2019s hormonal health: signs, prevalence, and risks of high cortisol, perimenopause, menopause, and emerging 2026 treatments.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.getasecondopinion.ai\/blog\/health-info\/conditions\/understanding-the-shift-hormonal-imbalance-high-cortisol-perimenopause-menopause-for-women\/\" \/>\n<meta property=\"og:site_name\" content=\"Get a Second Opinion\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/getasecondopinion\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-27T16:07:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-28T13:22:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.getasecondopinion.ai\/blog\/wp-content\/uploads\/2025\/10\/Menopause-Detail.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"G2O\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"G2O\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"14 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.getasecondopinion.ai\\\/blog\\\/health-info\\\/conditions\\\/understanding-the-shift-hormonal-imbalance-high-cortisol-perimenopause-menopause-for-women\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.getasecondopinion.ai\\\/blog\\\/health-info\\\/conditions\\\/understanding-the-shift-hormonal-imbalance-high-cortisol-perimenopause-menopause-for-women\\\/\"},\"author\":{\"name\":\"G2O\",\"@id\":\"https:\\\/\\\/www.getasecondopinion.ai\\\/blog\\\/#\\\/schema\\\/person\\\/9fbb863e981c8982fb301d0644843b20\"},\"headline\":\"Understanding the Shift: Hormonal Imbalance, High Cortisol, Perimenopause &#038; Menopause for Women\",\"datePublished\":\"2025-10-27T16:07:57+00:00\",\"dateModified\":\"2025-10-28T13:22:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.getasecondopinion.ai\\\/blog\\\/health-info\\\/conditions\\\/understanding-the-shift-hormonal-imbalance-high-cortisol-perimenopause-menopause-for-women\\\/\"},\"wordCount\":2995,\"publisher\":{\"@id\":\"https:\\\/\\\/www.getasecondopinion.ai\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.getasecondopinion.ai\\\/blog\\\/health-info\\\/conditions\\\/understanding-the-shift-hormonal-imbalance-high-cortisol-perimenopause-menopause-for-women\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.getasecondopinion.ai\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Menopause-Detail.jpg\",\"keywords\":[\"cortisol and menopause\",\"emerging menopause treatments\",\"high cortisol in women\",\"hormonal imbalance women\",\"menopause treatment 2026\",\"perimenopause hormone therapy\",\"perimenopause symptoms\",\"signs of hormonal imbalance\",\"women's hormonal health\"],\"articleSection\":[\"Conditions\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.getasecondopinion.ai\\\/blog\\\/health-info\\\/conditions\\\/understanding-the-shift-hormonal-imbalance-high-cortisol-perimenopause-menopause-for-women\\\/\",\"url\":\"https:\\\/\\\/www.getasecondopinion.ai\\\/blog\\\/health-info\\\/conditions\\\/understanding-the-shift-hormonal-imbalance-high-cortisol-perimenopause-menopause-for-women\\\/\",\"name\":\"Understanding the Shift: Hormonal Imbalance, High Cortisol, Perimenopause & Menopause for Women - Get a Second Opinion\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.getasecondopinion.ai\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.getasecondopinion.ai\\\/blog\\\/health-info\\\/conditions\\\/understanding-the-shift-hormonal-imbalance-high-cortisol-perimenopause-menopause-for-women\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.getasecondopinion.ai\\\/blog\\\/health-info\\\/conditions\\\/understanding-the-shift-hormonal-imbalance-high-cortisol-perimenopause-menopause-for-women\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.getasecondopinion.ai\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Menopause-Detail.jpg\",\"datePublished\":\"2025-10-27T16:07:57+00:00\",\"dateModified\":\"2025-10-28T13:22:44+00:00\",\"description\":\"Comprehensive guide to women\u2019s hormonal health: signs, prevalence, and risks of high cortisol, perimenopause, menopause, and emerging 2026 treatments.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.getasecondopinion.ai\\\/blog\\\/health-info\\\/conditions\\\/understanding-the-shift-hormonal-imbalance-high-cortisol-perimenopause-menopause-for-women\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.getasecondopinion.ai\\\/blog\\\/health-info\\\/conditions\\\/understanding-the-shift-hormonal-imbalance-high-cortisol-perimenopause-menopause-for-women\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.getasecondopinion.ai\\\/blog\\\/health-info\\\/conditions\\\/understanding-the-shift-hormonal-imbalance-high-cortisol-perimenopause-menopause-for-women\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.getasecondopinion.ai\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Menopause-Detail.jpg\",\"contentUrl\":\"https:\\\/\\\/www.getasecondopinion.ai\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Menopause-Detail.jpg\",\"width\":1536,\"height\":1024,\"caption\":\"Header illustration for an article on women\u2019s hormonal health showing a calm, middle-aged woman with shoulder-length gray hair and a hand over her chest on the right, set against abstract warm and cool-toned shapes; on the left, bold dark-blue title \u201cWOMEN\u2019S HORMONAL HEALTH\u201d and a smaller subtitle \u201cEffects of Cortisol, Menopause, Perimenopause & New Treatments for 2026\u201d placed on a semi-transparent off-white backer for clear readability.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.getasecondopinion.ai\\\/blog\\\/health-info\\\/conditions\\\/understanding-the-shift-hormonal-imbalance-high-cortisol-perimenopause-menopause-for-women\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Insights\",\"item\":\"https:\\\/\\\/www.getasecondopinion.ai\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Health Info\",\"item\":\"https:\\\/\\\/www.getasecondopinion.ai\\\/blog\\\/category\\\/health-info\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Conditions\",\"item\":\"https:\\\/\\\/www.getasecondopinion.ai\\\/blog\\\/category\\\/health-info\\\/conditions\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Understanding the Shift: Hormonal Imbalance, High Cortisol, Perimenopause &#038; Menopause for Women\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.getasecondopinion.ai\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.getasecondopinion.ai\\\/blog\\\/\",\"name\":\"Get a Second Opinion\",\"description\":\"Insights\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.getasecondopinion.ai\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.getasecondopinion.ai\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.getasecondopinion.ai\\\/blog\\\/#organization\",\"name\":\"Get a Second Opinion\",\"url\":\"https:\\\/\\\/www.getasecondopinion.ai\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.getasecondopinion.ai\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/getasecondopinion.ai\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/G2O-logo-full.png\",\"contentUrl\":\"https:\\\/\\\/getasecondopinion.ai\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/G2O-logo-full.png\",\"width\":1000,\"height\":129,\"caption\":\"Get a Second Opinion\"},\"image\":{\"@id\":\"https:\\\/\\\/www.getasecondopinion.ai\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/getasecondopinion\",\"https:\\\/\\\/www.instagram.com\\\/getasecondopinion\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.getasecondopinion.ai\\\/blog\\\/#\\\/schema\\\/person\\\/9fbb863e981c8982fb301d0644843b20\",\"name\":\"G2O\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/21b03bf2b185bfb0dd4d13c2214225de3355abca7b52e424ee73d37b573644a0?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/21b03bf2b185bfb0dd4d13c2214225de3355abca7b52e424ee73d37b573644a0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/21b03bf2b185bfb0dd4d13c2214225de3355abca7b52e424ee73d37b573644a0?s=96&d=mm&r=g\",\"caption\":\"G2O\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Understanding the Shift: Hormonal Imbalance, High Cortisol, Perimenopause & Menopause for Women - Get a Second Opinion","description":"Comprehensive guide to women\u2019s hormonal health: signs, prevalence, and risks of high cortisol, perimenopause, menopause, and emerging 2026 treatments.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.getasecondopinion.ai\/blog\/health-info\/conditions\/understanding-the-shift-hormonal-imbalance-high-cortisol-perimenopause-menopause-for-women\/","og_locale":"en_US","og_type":"article","og_title":"Understanding the Shift: Hormonal Imbalance, High Cortisol, Perimenopause & Menopause for Women - Get a Second Opinion","og_description":"Comprehensive guide to women\u2019s hormonal health: signs, prevalence, and risks of high cortisol, perimenopause, menopause, and emerging 2026 treatments.","og_url":"https:\/\/www.getasecondopinion.ai\/blog\/health-info\/conditions\/understanding-the-shift-hormonal-imbalance-high-cortisol-perimenopause-menopause-for-women\/","og_site_name":"Get a Second Opinion","article_publisher":"https:\/\/www.facebook.com\/getasecondopinion","article_published_time":"2025-10-27T16:07:57+00:00","article_modified_time":"2025-10-28T13:22:44+00:00","og_image":[{"width":1536,"height":1024,"url":"https:\/\/www.getasecondopinion.ai\/blog\/wp-content\/uploads\/2025\/10\/Menopause-Detail.jpg","type":"image\/jpeg"}],"author":"G2O","twitter_card":"summary_large_image","twitter_misc":{"Written by":"G2O","Est. reading time":"14 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.getasecondopinion.ai\/blog\/health-info\/conditions\/understanding-the-shift-hormonal-imbalance-high-cortisol-perimenopause-menopause-for-women\/#article","isPartOf":{"@id":"https:\/\/www.getasecondopinion.ai\/blog\/health-info\/conditions\/understanding-the-shift-hormonal-imbalance-high-cortisol-perimenopause-menopause-for-women\/"},"author":{"name":"G2O","@id":"https:\/\/www.getasecondopinion.ai\/blog\/#\/schema\/person\/9fbb863e981c8982fb301d0644843b20"},"headline":"Understanding the Shift: Hormonal Imbalance, High Cortisol, Perimenopause &#038; Menopause for Women","datePublished":"2025-10-27T16:07:57+00:00","dateModified":"2025-10-28T13:22:44+00:00","mainEntityOfPage":{"@id":"https:\/\/www.getasecondopinion.ai\/blog\/health-info\/conditions\/understanding-the-shift-hormonal-imbalance-high-cortisol-perimenopause-menopause-for-women\/"},"wordCount":2995,"publisher":{"@id":"https:\/\/www.getasecondopinion.ai\/blog\/#organization"},"image":{"@id":"https:\/\/www.getasecondopinion.ai\/blog\/health-info\/conditions\/understanding-the-shift-hormonal-imbalance-high-cortisol-perimenopause-menopause-for-women\/#primaryimage"},"thumbnailUrl":"https:\/\/www.getasecondopinion.ai\/blog\/wp-content\/uploads\/2025\/10\/Menopause-Detail.jpg","keywords":["cortisol and menopause","emerging menopause treatments","high cortisol in women","hormonal imbalance women","menopause treatment 2026","perimenopause hormone therapy","perimenopause symptoms","signs of hormonal imbalance","women's hormonal health"],"articleSection":["Conditions"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.getasecondopinion.ai\/blog\/health-info\/conditions\/understanding-the-shift-hormonal-imbalance-high-cortisol-perimenopause-menopause-for-women\/","url":"https:\/\/www.getasecondopinion.ai\/blog\/health-info\/conditions\/understanding-the-shift-hormonal-imbalance-high-cortisol-perimenopause-menopause-for-women\/","name":"Understanding the Shift: Hormonal Imbalance, High Cortisol, Perimenopause & Menopause for Women - Get a Second Opinion","isPartOf":{"@id":"https:\/\/www.getasecondopinion.ai\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.getasecondopinion.ai\/blog\/health-info\/conditions\/understanding-the-shift-hormonal-imbalance-high-cortisol-perimenopause-menopause-for-women\/#primaryimage"},"image":{"@id":"https:\/\/www.getasecondopinion.ai\/blog\/health-info\/conditions\/understanding-the-shift-hormonal-imbalance-high-cortisol-perimenopause-menopause-for-women\/#primaryimage"},"thumbnailUrl":"https:\/\/www.getasecondopinion.ai\/blog\/wp-content\/uploads\/2025\/10\/Menopause-Detail.jpg","datePublished":"2025-10-27T16:07:57+00:00","dateModified":"2025-10-28T13:22:44+00:00","description":"Comprehensive guide to women\u2019s hormonal health: signs, prevalence, and risks of high cortisol, perimenopause, menopause, and emerging 2026 treatments.","breadcrumb":{"@id":"https:\/\/www.getasecondopinion.ai\/blog\/health-info\/conditions\/understanding-the-shift-hormonal-imbalance-high-cortisol-perimenopause-menopause-for-women\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.getasecondopinion.ai\/blog\/health-info\/conditions\/understanding-the-shift-hormonal-imbalance-high-cortisol-perimenopause-menopause-for-women\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.getasecondopinion.ai\/blog\/health-info\/conditions\/understanding-the-shift-hormonal-imbalance-high-cortisol-perimenopause-menopause-for-women\/#primaryimage","url":"https:\/\/www.getasecondopinion.ai\/blog\/wp-content\/uploads\/2025\/10\/Menopause-Detail.jpg","contentUrl":"https:\/\/www.getasecondopinion.ai\/blog\/wp-content\/uploads\/2025\/10\/Menopause-Detail.jpg","width":1536,"height":1024,"caption":"Header illustration for an article on women\u2019s hormonal health showing a calm, middle-aged woman with shoulder-length gray hair and a hand over her chest on the right, set against abstract warm and cool-toned shapes; on the left, bold dark-blue title \u201cWOMEN\u2019S HORMONAL HEALTH\u201d and a smaller subtitle \u201cEffects of Cortisol, Menopause, Perimenopause & New Treatments for 2026\u201d placed on a semi-transparent off-white backer for clear readability."},{"@type":"BreadcrumbList","@id":"https:\/\/www.getasecondopinion.ai\/blog\/health-info\/conditions\/understanding-the-shift-hormonal-imbalance-high-cortisol-perimenopause-menopause-for-women\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Insights","item":"https:\/\/www.getasecondopinion.ai\/blog\/"},{"@type":"ListItem","position":2,"name":"Health Info","item":"https:\/\/www.getasecondopinion.ai\/blog\/category\/health-info\/"},{"@type":"ListItem","position":3,"name":"Conditions","item":"https:\/\/www.getasecondopinion.ai\/blog\/category\/health-info\/conditions\/"},{"@type":"ListItem","position":4,"name":"Understanding the Shift: Hormonal Imbalance, High Cortisol, Perimenopause &#038; Menopause for Women"}]},{"@type":"WebSite","@id":"https:\/\/www.getasecondopinion.ai\/blog\/#website","url":"https:\/\/www.getasecondopinion.ai\/blog\/","name":"Get a Second Opinion","description":"Insights","publisher":{"@id":"https:\/\/www.getasecondopinion.ai\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.getasecondopinion.ai\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.getasecondopinion.ai\/blog\/#organization","name":"Get a Second Opinion","url":"https:\/\/www.getasecondopinion.ai\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.getasecondopinion.ai\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/getasecondopinion.ai\/blog\/wp-content\/uploads\/2025\/09\/G2O-logo-full.png","contentUrl":"https:\/\/getasecondopinion.ai\/blog\/wp-content\/uploads\/2025\/09\/G2O-logo-full.png","width":1000,"height":129,"caption":"Get a Second Opinion"},"image":{"@id":"https:\/\/www.getasecondopinion.ai\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/getasecondopinion","https:\/\/www.instagram.com\/getasecondopinion"]},{"@type":"Person","@id":"https:\/\/www.getasecondopinion.ai\/blog\/#\/schema\/person\/9fbb863e981c8982fb301d0644843b20","name":"G2O","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/21b03bf2b185bfb0dd4d13c2214225de3355abca7b52e424ee73d37b573644a0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/21b03bf2b185bfb0dd4d13c2214225de3355abca7b52e424ee73d37b573644a0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/21b03bf2b185bfb0dd4d13c2214225de3355abca7b52e424ee73d37b573644a0?s=96&d=mm&r=g","caption":"G2O"}}]}},"_links":{"self":[{"href":"https:\/\/www.getasecondopinion.ai\/blog\/wp-json\/wp\/v2\/posts\/597","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.getasecondopinion.ai\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.getasecondopinion.ai\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.getasecondopinion.ai\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.getasecondopinion.ai\/blog\/wp-json\/wp\/v2\/comments?post=597"}],"version-history":[{"count":2,"href":"https:\/\/www.getasecondopinion.ai\/blog\/wp-json\/wp\/v2\/posts\/597\/revisions"}],"predecessor-version":[{"id":602,"href":"https:\/\/www.getasecondopinion.ai\/blog\/wp-json\/wp\/v2\/posts\/597\/revisions\/602"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.getasecondopinion.ai\/blog\/wp-json\/wp\/v2\/media\/599"}],"wp:attachment":[{"href":"https:\/\/www.getasecondopinion.ai\/blog\/wp-json\/wp\/v2\/media?parent=597"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.getasecondopinion.ai\/blog\/wp-json\/wp\/v2\/categories?post=597"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.getasecondopinion.ai\/blog\/wp-json\/wp\/v2\/tags?post=597"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}